Min‐Chi Lu
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 2%
- Enterobacteriaceae and Cronobacter Research
- Escherichia coli research studies
Papers in
-
- Antibiotic Resistance in Bacteria 28
-
- Antimicrobial Resistance in Staphylococcus 5
- Tuberculosis Research and Epidemiology 5
- Co-authors
- Yi‐Chyi Lai (22 shared papers)Po‐Ren Hsueh (23 shared papers)Wen‐Chien Ko (24 shared papers)Ming‐Ko Chiang (10 shared papers)Ying-Tsong Chen (7 shared papers)Chien‐Shun Chiou (13 shared papers)Huiling Tang (10 shared papers)Po‐Yu Liu (4 shared papers)
- Journals
- Journal of Microbiology Immunology and Infection (19 papers)International Journal of Antimicrobial Agents (7 papers)PLoS ONE (4 papers)Journal of Antimicrobial Chemotherapy (2 papers)Diagnostic Microbiology and Infectious Disease (2 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Min‐Chi Lu
81 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 124
- Molecular Medicine 722
- Endocrinology 259
- Applied Microbiology and Biotechnology 83
- Infectious Diseases 412
- Clinical Biochemistry 133
Countries citing papers authored by Min‐Chi Lu
This map shows the geographic impact of Min‐Chi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min‐Chi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min‐Chi Lu more than expected).
Fields of papers citing papers by Min‐Chi Lu
This network shows the impact of papers produced by Min‐Chi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min‐Chi Lu. The network helps show where Min‐Chi Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Min‐Chi Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 92 | |
| 2 | 2009 | 74 | |
| 3 | 2005 | 74 | |
| 4 | 2021 | 72 | |
| 5 | 2017 | 72 | |
| 6 | 2014 | 68 | |
| 7 | 2020 | 67 | |
| 8 | 2014 | 66 | |
| 9 | 2020 | 66 | |
| 10 | 2015 | 52 | |
| 11 | 2005 | 48 | |
| 12 | 2021 | 47 | |
| 13 | 2017 | 46 | |
| 14 | 2011 | 45 | |
| 15 | 2017 | 40 | |
| 16 | 2009 | 38 | |
| 17 | 2006 | 35 | |
| 18 | 2017 | 35 | |
| 19 | 2019 | 34 | |
| 20 | 2014 | 33 |
About Min‐Chi Lu
Min‐Chi Lu is a scholar working on Molecular Medicine, Infectious Diseases, Epidemiology, Molecular Biology and Endocrinology, having authored 83 papers that have together received 1.9k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (28 papers), Pneumonia and Respiratory Infections (9 papers), Enterobacteriaceae and Cronobacter Research (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Bacterial Identification and Susceptibility Testing (5 papers), Tuberculosis Research and Epidemiology (5 papers), Antibiotic Use and Resistance (5 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Molecular Medicine (722 citations), Endocrinology (259 citations), Applied Microbiology and Biotechnology (83 citations), Infectious Diseases (412 citations) and Clinical Biochemistry (133 citations). Min‐Chi Lu has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Yi‐Chyi Lai, Po‐Ren Hsueh, Wen‐Chien Ko, Ming‐Ko Chiang, Ying-Tsong Chen, Chien‐Shun Chiou, Huiling Tang, Po‐Yu Liu, Yaochen Wang and Chih‐Cheng Lai. Their work appears in journals such as Journal of Microbiology Immunology and Infection, International Journal of Antimicrobial Agents, PLoS ONE, Journal of Antimicrobial Chemotherapy and Diagnostic Microbiology and Infectious Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.